PlainRecalls
FDA Drug Moderate Class II Terminated

METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24

Reported: March 1, 2017 Initiated: February 10, 2017 #D-0480-2017

Product Description

METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24

Reason for Recall

Lack of Sterility Assurance: customer report of leaking bag

Details

Units Affected
578,784 bags
Distribution
Nationwide and Puerto Rico
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24. Recalled by Hospira Inc., A Pfizer Company. Units affected: 578,784 bags.
Why was this product recalled?
Lack of Sterility Assurance: customer report of leaking bag
Which agency issued this recall?
This recall was issued by the FDA Drug on March 1, 2017. Severity: Moderate. Recall number: D-0480-2017.